Stayble Therapeutics

Treating low back pain

  • CEO: Andreas Gerward
  • First investment year: 2016
  • Fund: West Sweden
  • Business sector: Life Science
Stayble Therapeutics

Stayble Therapeutics develops an injectable treatment against chronic low back pain triggered by disc degeneration. The treatment is presumed to last the patient’s entire life and require minimal rehabilitation.